国际口腔医学杂志 ›› 2017, Vol. 44 ›› Issue (3): 325-331.doi: 10.7518/gjkq.2017.03.015
刘锦丽, 陈方曼, 江潞
Liu Jinli, Chen Fangman, Jiang Lu.
摘要: 由于口腔黏膜下纤维性变(OSF)发病机制复杂,目前尚缺乏特效治疗手段,主要治疗方式仍为药物治疗。本文回顾介绍了近年来国内外临床上治疗OSF的药物种类,并主张根据疾病的病程选择不同的药物治疗。
中图分类号:
[1] Singh M, Niranjan HS, Mehrotra R, et al. Efficacy of hydrocortisone acetate/hyaluronidase vs triamcino-lone acetonide/hyaluronidase in the treatment of oral submucous fibrosis[J]. Indian J Med Res, 2010, 131(5):665-669. [2] Kiran Kumar K, Saraswathi TR, Ranganathan K, et al. Oral submucous fibrosis: a clinico-histopathological study in Chennai[J]. Indian J Dent Res, 2007, 18(3): 106-111. [3] Haque MF, Meghji S, Nazir R, et al. Interferon gamma(IFN-γ) may reverse oral submucous fibrosis [J]. J Oral Pathol Med, 2001, 30(1):12-21. [4] Golay A, Ferrara JM, Felber JP, et al. Cholesterol-lowering effect of skim milk from immunized cows in hypercholesterolemic patients[J]. Am J Clin Nutr, 1990, 52(6):1014-1019. [5] Tai YS, Liu BY, Wang JT, et al. Oral administration of milk from cows immunized with human intestinal bacteria leads to significant improvements of symp-toms and signs in patients with oral submucous fib-rosis[J]. J Oral Pathol Med, 2001, 30(10):618-625. [6] Jirge V, Shashikanth MC, Ali IM, et al. Levamisole and antioxidants in the management of oral submu-cous fibrosis: a comparative study[J]. J Indian Acad Oral Med Radiol, 2008, 20(4):135. [7] Lin HJ, Lin JC. Treatment of oral submucous fibro-sis by collagenase: effects on oral opening and eating function[J]. Oral Dis, 2007, 13(4):407-413. [8] Kakar PK, Puri RK, Venkatachalam VP. Oral sub-mucous fibrosis—treatment with hyalase[J]. J Laryn-gol Otol, 1985, 99(1):57-59. [9] Auluck A, Rosin MP, Zhang L, et al. Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature [J]. J Can Dent Assoc, 2008, 74(8):735-740. [10] Pineda AM, Tianco EA, Tan JB, et al. Oral pentoxi-fylline and topical clobetasol propionate ointment in the treatment of pretibial myxoedema, with concomi-tant improvement of Graves’ ophthalmopathy[J]. J Eur Acad Dermatol Venereol, 2007, 21(10):1441- 1443. [11] Rajendran R, Rani V, Shaikh S. Pentoxifylline therapy: a new adjunct in the treatment of oral sub-mucous fibrosis[J]. Indian J Dent Res, 2007, 17(4): 190-198. [12] Patil S, Maheshwari S. Efficacy of pentoxifylline in the management of oral submucous fibrosis[J]. J Orofac Sci, 2014, 6(2):94. [13] Lai DR, Chen HR, Lin LM, et al. Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases[J]. J Oral Pathol Med, 1995, 24(9):402-406. [14] Sharma JK, Gupta AK, Mukhija RD, et al. Clinical experience with the use of peripheral vasodilator in oral disorders[J]. Int J Oral Maxillofac Surg, 1987, 16(6):695-699. [15] Bhadage CJ, Umarji HR, Shah K, et al. Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis[J]. Clin Oral Investig, 2013, 17(5):1375- 1382. [16] Chole RH, Gondivkar SM, Gadbail AR, et al. Review of drug treatment of oral submucous fibrosis[J]. Oral Oncol, 2012, 48(5):393-398. [17] Maher R, Aga P, Johnson NW, et al. Evaluation of multiple micronutrient supplementation in the mana-gement of oral submucous fibrosis in Karachi, Pakis-tan[J]. Nutr Cancer, 1997, 27(1):41-47. [18] Dhariwal R, Mukherjee S, Mohanty SP, et al. Zinc and vitamin A can minimise the severity of oral submucous fibrosis[J]. BMJ Case Rep, 2010, 2010:bcr1020092348. [19] Kumar A, Bagewadi A, Keluskar V, et al. Efficacy of lycopene in the management of oral submucous fibrosis[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 103(2):207-213. [20] Biswas G, Anup N, Kumawat H. Efficacy of lyco-pene in the management of oral submucous fib-rosis—a randomized clinical trial[J]. Indian J Public Health Res Development, 2015, 6(3):33-37. [21] Mathew B, Sankaranarayanan R, Nair PP, et al. Evaluation of chemoprevention of oral cancer with Spirulina fusiformis [J]. Nutr Cancer, 1995, 24(2): 197-202. [22] Shetty P, Shenai P, Chatra L, et al. Efficacy of spiru-lina as an antioxidant adjuvant to corticosteroid injection in management of oral submucous fibrosis [J]. Indian J Dent Res, 2013, 24(3):347-350. [23] Patil S, Halgatti V, Maheshwari S, et al. Comparative study of the efficacy of herbal antioxdants oxitard and aloe vera in the treatment of oral submucous fibrosis[J]. J Clin Exp Dent, 2014, 6(3):e265-e270. [24] 李新民, 唐杰清. 茶色素治疗口腔粘膜下纤维性变的临床观察[J]. 华西口腔医学杂志, 1998, 16(1):50- 52. Li XM, Tang JQ. Clinical treatment observation of tea pigment for oral submucous fibrosis[J]. West Chin J Stomatol, 1998, 16(1):50-52. [25] Gupta D, Sharma SC. Oral submucous fibrosis—a new treatment regimen[J]. J Oral Maxillofac Surg, 1988, 46(10):830-833. [26] Jiang XW, Zhang Y, Yang SK, et al. Efficacy of salvianolic acid B combined with triamcinolone ace-tonide in the treatment of oral submucous fibrosis[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2013, 115(3):339-344. [27] Alok A, Singh ID, Singh S, et al. Curcumin-pharma-cological actions and its role in oral submucous fib-rosis: a review[J]. J Clin Diagn Res, 2015, 9(10):ZE01-ZE03. [28] Rai B, Kaur J, Jacobs R, et al. Possible action me-chanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress[J]. J Oral Sci, 2010, 52(2):251-256. [29] Joshi J, Ghaisas S, Vaidya A, et al. Early human safety study of turmeric oil(Curcuma longa oil) administered orally in healthy volunteers[J]. J Assoc Physicians India, 2003, 51:1055-1060. [30] Ramadass T, Manokaran G, Pushpala SM, et al. Oral submucous fibrosis-New dimensions in surgery[J]. Indian J Otolaryngol Head Neck Surg, 2005, 57(2): 99-102. [31] Sudarshan R, Annigeri RG, Vijayabala GS. Aloe vera in the treatment for oral submucous fibrosis-a preliminary study[J]. J Oral Pathol Med, 2012, 41(10):755-761. [32] Anil S, Beena VT. Oral submucous fibrosis in a 12-year-old girl: case report[J]. Pediatr Dent, 1993, 15(2):120-122. [33] Katharia SK, Singh SP, Kulshreshtha VK. The effects of placenta extract in management of oral submucous fibrosis[J]. Indian J Pharmacol, 1992, 24(3):181-183. |
[1] | 常欣楠,刘磊. 生物可降解镁基材料在颅颌面外科的应用及其研究进展[J]. 国际口腔医学杂志, 2024, 51(1): 107-115. |
[2] | 戢晓,朱桂全. 维生素D与药物相关性颌骨坏死关系的研究进展[J]. 国际口腔医学杂志, 2022, 49(4): 441-447. |
[3] | 梁屹,裴锡波,万乾炳. 光响应水凝胶在生物医学领域应用的研究进展[J]. 国际口腔医学杂志, 2022, 49(1): 12-18. |
[4] | 郭雨婷,吕学超. 药物调控牙髓干细胞成骨分化的研究进展[J]. 国际口腔医学杂志, 2021, 48(6): 737-744. |
[5] | 李妍,孟琛达,徐全臣. 药物性牙龈肥大的病因研究及治疗进展[J]. 国际口腔医学杂志, 2020, 47(6): 693-698. |
[6] | 张敏,万浩元. 种植体周围炎药物治疗与激光治疗的研究进展[J]. 国际口腔医学杂志, 2020, 47(4): 463-470. |
[7] | 吴秋月,李治邦. 药物辅助治疗种植体周围炎的研究进展[J]. 国际口腔医学杂志, 2020, 47(4): 471-477. |
[8] | 周婷茹,李永生. 牙髓干细胞成骨微环境的研究进展[J]. 国际口腔医学杂志, 2019, 46(6): 675-679. |
[9] | 程国平,丁一,郭淑娟. 静电纺丝纤维作为牙周药物传递系统的研究进展[J]. 国际口腔医学杂志, 2019, 46(5): 565-570. |
[10] | 叶畅畅, 赵蕾, 王冬青, 王晓丽, 王海燕, 游梦, 黄萍, 吴亚菲. 妊娠期牙周疾病的防治策略[J]. 国际口腔医学杂志, 2018, 45(5): 501-508. |
[11] | 吉宁, 赵行, 曾昕, 陈谦明. 核苷类抗疱疹病毒药物的研究进展[J]. 国际口腔医学杂志, 2018, 45(3): 351-357. |
[12] | 张艺馨, 李磊. 磷酸钙支架-药物缓释体系在骨组织工程中的研究进展[J]. 国际口腔医学杂志, 2018, 45(3): 346-350. |
[13] | 肖妍荻, 杨华梅, 但红霞. 抗肿瘤靶向药物相关不良反应在口腔中的表现及处理对策[J]. 国际口腔医学杂志, 2018, 45(2): 140-144. |
[14] | 詹烨明, 张明珠. 药物性牙龈增生与细胞增殖和凋亡相关性的研究进展[J]. 国际口腔医学杂志, 2018, 45(2): 199-203. |
[15] | 王智. 系统性疾病唇部损害的诊断及临床处理[J]. 国际口腔医学杂志, 2018, 45(2): 125-131. |
|